These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 8846949)
1. [Clozapine for resistant schizophrenia and characteristics of those responding]. Talmon Y; Guy N; Wittenberg N Harefuah; 1995 Dec; 129(11):451-4, 536. PubMed ID: 8846949 [TBL] [Abstract][Full Text] [Related]
2. [Clozapine in the treatment of under-age schizophrenia]. Haapasalo-Pesu KM Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179 [TBL] [Abstract][Full Text] [Related]
3. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center]. Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P Encephale; 1998; 24(4):365-77. PubMed ID: 9809242 [TBL] [Abstract][Full Text] [Related]
4. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732 [TBL] [Abstract][Full Text] [Related]
5. Clozapine treatment after agranulocytosis induced by classic neuroleptics. Bauer M; Mackert A J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676 [TBL] [Abstract][Full Text] [Related]
6. Implications for anaesthesia in a patient established on clozapine treatment. Doherty J; Bell PF; King DJ Int J Obstet Anesth; 2006 Jan; 15(1):59-62. PubMed ID: 16256331 [TBL] [Abstract][Full Text] [Related]
9. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Hägg S; Rosenius S; Spigset O Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898 [TBL] [Abstract][Full Text] [Related]
10. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies. Zipris P; Melamed Y; Weizman A; Bleich A Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812 [TBL] [Abstract][Full Text] [Related]
11. Predictors of clozapine discontinuation in patients with schizophrenia. Krivoy A; Malka L; Fischel T; Weizman A; Valevski A Int Clin Psychopharmacol; 2011 Nov; 26(6):311-5. PubMed ID: 21849905 [TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026 [TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia and diabetes mellitus: not an improbable combination]. Cohen D; Gispen-de Wied CC Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967 [TBL] [Abstract][Full Text] [Related]
17. Exacerbation of tics secondary to clozapine therapy. Bastiampillai T; Dhillon R; Mohindra R Aust N Z J Psychiatry; 2008 Dec; 42(12):1068-70. PubMed ID: 19034993 [No Abstract] [Full Text] [Related]
18. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C; Bret P; Bret MC; Queuille E Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [TBL] [Abstract][Full Text] [Related]
19. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia. Zink M; Mase E; Dressing H Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656 [TBL] [Abstract][Full Text] [Related]
20. Prescribing and monitoring clozapine in Christchurch. McKean A; Vella-Brincat J; Begg E Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]